Skip to content
RareCan logo

RareCan Alternatives & Competitors

12 companies similar to RareCan — RareCan aims to accelerate research and ultimately improve treatments and outcom...

Companies similar to RareCan

Perlegen Sciences logo — alternative to RareCan

Perlegen Sciences

Uncovering genetic insights to elevate clinical decisions and enhance patient outcomes.

Precision For Medicine logo — alternative to RareCan
Sano Genetics logo — alternative to RareCan

Sano Genetics

Accelerating the world's transition to precision medicine.

H1 logo — alternative to RareCan

H1

H1 is the connecting force for global HCP, clinical, scientific and research information.

Rival Readout

Competing with RareCan? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Photolitec LLC logo — alternative to RareCan

Photolitec LLC

See, Diagnose and Treat

Elligo Health Research logo — alternative to RareCan
AllStripes (now PicnicHealth) logo — alternative to RareCan

AllStripes (now PicnicHealth)

Unlocking new treatments for people with rare disease

D2V Clinical logo — alternative to RareCan

D2V Clinical

Expertise that Translates INDs into Clinical Milestones

Forma Therapeutics logo — alternative to RareCan

Forma Therapeutics

Dedicated to transforming the lives of patients with rare hematologic diseases and cancers...

Linear Clinical Research Ltd logo — alternative to RareCan

Linear Clinical Research Ltd

Changing lives with medical research.

VivoSense, Inc. logo — alternative to RareCan

VivoSense, Inc.

Advancing clinical trials research and healthcare delivery with analytics & AI for all wea...

TwinStrand Biosciences logo — alternative to RareCan

TwinStrand Biosciences

Ultra-rare variants are detected with unparalleled sensitivity and specificity with TwinSt...

About RareCan

RareCan is a United Kingdom-based biotechnology and healthcare company, founded in 2019, with a mission to accelerate research and improve treatments for individuals with rare cancers. The company has recently secured a £374.88K Equity Crowdfunding investment on 15 June 2022 through Crowdcube. RareCan addresses the pre...

Business keywords

Rare Cancers, Clinical Trials, Patient Recruitment, Research Acceleration, Bio-samples, Genetic Data, NHS Trusts, Patient Organizations, Cancer Research, Data Access, Treatment Outcomes, Precision Cohort, Histology-independent Trials, Life Sciences Companies, Global Research Network

Frequently Asked Questions

Companies similar to RareCan include Perlegen Sciences, Precision For Medicine, Sano Genetics, H1, Photolitec LLC. They work in Biotechnology and Health Care and share RareCan's focus on clinical trials, patient recruitment and cancer research.
Bounce Watch lists 12 companies that share RareCan's industries and are closest to it in business tags, services, target customers, business model and size.
RareCan is a United Kingdom-based biotechnology and healthcare company, founded in 2019, with a mission to accelerate research and improve treatments for individuals with rare cancers. The company has recently secured a £374.88K Equity Crowdfunding investment on 15 June 2022 through Crowdcube. RareCan addresses the pre...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around RareCan: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at RareCan on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout